Citius Pharma(CTXR.US)

Last Updated 19:00:00 ET
longbridge loading

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
GOSS
-10.68%
US
LTRN
-1.26%
US
AIM
-1.66%
benzinga_article·
US
GOSS
-10.68%
US
LTRN
-1.26%
US
AIM
-1.66%

16:30 ETCitius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

prnewswire·
US
CTXR
+8.43%
US
PBE
-0.28%
US
BBH
+0.32%
prnewswire·
US
CTXR
+8.43%
US
PBE
-0.28%
US
BBH
+0.32%

Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update | CTOR Stock News

StockTitan·
US
CTOR
-0.75%
StockTitan·
US
CTOR
-0.75%

Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility

Tip Ranks·
US
CTXR
+8.43%
US
CTOR
-0.75%
US
LABU
-0.29%
Tip Ranks·
US
CTXR
+8.43%
US
CTOR
-0.75%
US
LABU
-0.29%

Citius raises $36.5m for Lymphir commercialisation

Pharmaceutical Technology·
US
CTXR
+8.43%
Pharmaceutical Technology·
US
CTXR
+8.43%

Citius Pharmaceuticals Raises ~$5M; Issues Warrants in Registered Direct and Private Placement

TradingView·
US
CTXR
+8.43%
US
XBI
-0.06%
US
SBIO
+0.62%
TradingView·
US
CTXR
+8.43%
US
XBI
-0.06%
US
SBIO
+0.62%

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules | CTXR Stock News

StockTitan·
US
CTXR
+8.43%
StockTitan·
US
CTXR
+8.43%
© 2026 Longbridge｜Disclaimer